Pathophysiology of aortic stenosis and approach to treatment with percutaneous valve implantation

Circulation Journal

Volumn 75, Issue 1, 2011, Pages 11-19

  Spaccarotella, Carmen ^a   Mongiardo, Annalisa ^a   Indolfi, Ciro ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Aortic stenosis; Elderly; Percutaneous valve implantation; Transcatheter aortic valve implantation (TAVI)

Indexed keywords

ACUTE KIDNEY FAILURE; AORTA PRESSURE; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTIFICIAL HEART PACEMAKER; CEREBROVASCULAR ACCIDENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; FOLLOW UP; HEART AFTERLOAD; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART OUTPUT; HEART PRELOAD; HEART STROKE VOLUME; HEART TAMPONADE; HUMAN; INTERMETHOD COMPARISON; PATHOPHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PROSTHESIS FAILURE; REVIEW; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL RISK; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION;

AGED; ANIMALS; AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 78651234444     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1105     Document Type: Review

References (31)

1. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
2. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease. Eur Heart J 2003; 24: 1231-1243.
3. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: Results from a cohort of 277 patients aged ≥80 years. Euro J Cardiothorac Surg 2006; 30: 722-727.
4. Piazza N, de Jaegere P, Schultz C, Becker E, Serruys PW, Anderson R H. Anatomy of the aortic complex and its implications for trans-catheter implantation of the aortic valve. Circ Cardiovasc Intervent 2008; 1: 74-81.
5. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113: 842-850.
6. Ross J, Braunwald E. Aortic Stenosis. Circulation 1968; 38(Suppl): 61-67.
7. Gravanis MB, Robinson PH, Hertzler GL. Hypertrophic cardio-myopathy evolving into a hypokinetic and dilated left ventricle: Coronary embolization as a probable pathogenetic mechanism. Clin Cardiol 1990; 13: 500-505.
8. Ross J, Braunwald E. The study of left ventricular function in man by increasing resistance to ventricular ejection with angioten-sin. Circulation 1964; 29: 733-749.
9. Ross J, Covell JW, Sonnenblick EH, Braunwald E. Contractile state of the heart characterized by force-velocity relations in variably afterloaded and isovolumic beats. Circ Res 1966; 18: 149-163.
10. acGregor DC, Covell JW, Mahler F, Dilly RB, Ross J. Relations between afterload, stroke volume, and descending limb of Starling's curve. Am J Physiol 1974; 227: 884-890.
11. Ross J. Afterload mismatch and preload reserve: A conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976; 18: 255-264.
12. Otto CM. Valvular aortic stenosis: Disease severity and timing of intervention. J Am Coll Cardiol 2006; 47: 2141-2149.
13. Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S, et al. Natural history of very severe aortic stenosis. Circulation 2010; 121: 151-156.
14. Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: Beneft of aortic valve replacement. Ann Thorac Surg 2006; 82: 2116-2122.
15. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, et al. Prospective study of asymptomatic valvular aortic stenosis: Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95: 2262-2270.
16. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: The potential role of subjectively overestimated operative risk. Circ Cardio-vasc Qual Outcomes 2009; 2: 533-539.
17. Hara H, Schwartz RS. Transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. Circ J 2010; 74: 1513-1517.
18. Kawachi Y, Nakashima A, Kosuga T, Tomoeda H, Nishimura Y, Toshima Y. Early and late results of cardiac and thoracic aortic surgery in octogenarian: Comparison with high-risk younger patients. Circ J 2003; 67: 539-544.
19. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76.
20. Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, et al. A implantation with the corevalve revalving system safety and effcacy of the subclavian approach for transcatheter aortic valve. Circ Cardiovasc Interv 2010; 3: 359-366.
21. ® Registry. Transcatheter Cardiovascular Therapeutics 2009, September 21-25, 2009. San Francisco, CA, USA.
22. Avanzas P, Muñoz-García AJ, Segura J, Pan M, Alonso-Briales JH, Lozano I, et al. Percutaneous implantation of the CoreValve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: Early experience in Spain. Rev Esp Cardiol 2010; 63: 141-148.
23. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, et al, On behalf of the FRANCE Registry Investigators. Transcatheter aortic valve implantation: Early results of the FRANCE (FRench Aortic National CoreValve and Edwards) Registry. Eur Heart J 2010 Sep 15 [Epub ahead of print].
24. Bosmans, Belgian Registry TAVI Facts Figures and National Registries. EuroPCR 2010 Paris, Abstract presentation.
25. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, et al, On behalf of the German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur Heart J 2010 Sep 23 [E-pub ahead of print].
26. Ludman, UK Registry TAVI Facts Figures and National Registries. EuroPCR 2010 Paris, Abstract presentation.
27. Petronio AS. Italian Registry, TAVI Facts, Figures and National Registries. EuroPCR 2010, Paris, France, Abstract presentation.
28. Rodés-Cabaua J. Progress in transcatheter aortic valve implantation. Rev Esp Cardiol 2010; 63: 439-450.
29. Latsios G, Gerckens U, Buellesfeld L, Mueller R, John D, Yuecel S, et al. Device landing zone calcifcation, assessed by MSCT, as predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 2010; 76: 431-439.
30. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, et al. Thirty-day results of the SAPIEN aortic biopro implantation using the Edwards SAPIEN valvesthesis european outcome (SOURCE) registry: A European registry of transcatheter aortic valve. Circulation 2010; 122: 62-69.
31. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.